Patents
Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
02/2009
02/04/2009CN101357909A 1,3,4-thiadiazole aroyl urea compound, preparation method and application thereof
02/04/2009CN100457735C Therapeutic agents useful for treating pain
02/03/2009CA2420040C New phenylalanine derivatives
01/2009
01/29/2009WO2008063781A3 Chemical compounds as cannabinoid receptor ligands
01/29/2009US20090029995 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
01/28/2009CN101356149A Indene derivatives, their preparation and use as medicaments
01/27/2009US7482490 2,7-Di(4,4,5,5-tetramethyl-1,3,2-dioxa-borolan-2-yl)-9,9'-bis(4-methoxymethyloxyphenyl)-9H-fluorene, for example; can be utilized as hole transport materials, hole injection materials or the like of organic electroluminescence devices, electrophotographic receptors
01/27/2009US7482465 Indol derivatives and their use as 5-HT ligands
01/27/2009CA2247443C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
01/22/2009WO2009012283A1 Compounds and methods for kinase modulation, and indications therefor
01/22/2009WO2009011871A2 Thiadiazole modulators of pkb
01/22/2009WO2009010429A2 Novel heterocyclyl compounds and their use as chemokine antagonists
01/22/2009US20090023730 such as 1-(3-tert-butyl-1-methyl-1H-pyrazole-5-carbonyl)-3-(4-(pentyloxy)-3-(trifluoromethyl)phenyl)thiourea; packages, patches; hepatitis virus infections
01/22/2009CA2695998A1 Novel heterocyclyl compounds
01/22/2009CA2695004A1 Compounds and methods for kinase modulation, and indications therefor
01/22/2009CA2693473A1 Thiadiazole modulators of pkb
01/15/2009WO2009008748A1 Pyrazolo[1,5-a]pyridines and their use in cancer therapy
01/15/2009US20090018056 Heteroarylcarbamoylbenzene derivatives
01/15/2009CA2692653A1 Pyrazolo[1,5-.alpha.]pyridines and their use in cancer therapy
01/14/2009EP2014285A1 NPYY5 antagonists
01/14/2009CN100451009C Diazosulfide derivative and its synthesis and screening method for inducing anti-disease activity
01/13/2009US7476686 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea; viricides; Hepatitis C infection
01/13/2009US7476261 Hair dye composition
01/08/2009US20090012131 4-oxy-n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for their therapeutic use
01/06/2009US7473790 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
01/01/2009US20090005549 Processes and Reagents for Desilylation of Oligonucleotides
12/2008
12/31/2008WO2008128072A3 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
12/31/2008EP2007717A1 Novel sulfonamide compounds
12/31/2008CN101336235A 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
12/30/2008US7470807 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
12/30/2008US7470700 Such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile; type 2 diabetes mellitus, diabetic dislipidemia, impaired glucose tolerance
12/29/2008CA2636734A1 Metal coordinated compositions
12/25/2008US20080318956 Inflammatory cytokine release inhibitor
12/25/2008US20080318936 Substituted 5-Phenyl-3,6-Dihydro-2-Oxo-6H-1,3,4-Thiadiazines
12/24/2008WO2008157407A2 Thiadiazole, oxadiazole and triazole derivatives for treating leukemia
12/24/2008WO2008076754A3 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity
12/24/2008WO2008033455A3 Biphenyl and heteroaryl phenyl derivatives as protein tyrosine phosphatases inhibitors
12/24/2008CN100445274C 2,1,3-benzothiadiazoles for use as electronic active components
12/24/2008CN100445272C Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity
12/23/2008CA2331685C Use of compounds for the elevation of pyruvate dehydrogenase activity
12/23/2008CA2238427C Production method of aminobenzene compound
12/18/2008WO2008151513A1 Suspension concentrate of zn thiodiazole and preparation thereof
12/18/2008US20080312207 Compounds
12/17/2008CN101326173A Thiadiazoles derivant as anti-diabetes agent
12/17/2008CN101323603A Preparation of 2-amido-1,3,4-thiadiazoles
12/11/2008WO2008148744A1 Thiadiazole derivatives as antidiabetic agents
12/11/2008US20080306053 Modulation of chemosensory receptors and ligands associated therewith
12/11/2008US20080306052 e.g.1-{3-[5-(4-chlorophenyl)-2-oxo-6H-1,3,4-thiadiazin-3-ylmethyl]phenyl}-3-(1-methylpyrrolidin-3-ylmethyl)urea; inhibitors of tyrosine kinases, in particular Met kinase; antitumor, antiinflammatory agent
12/10/2008CN101321743A L , l , 3-tri0x0-l , 2 , 5-thiadiaz0lidines and their use as PTP-ases inhibitors
12/10/2008CN100441182C Nociceptin analogs
12/09/2008US7462628 Preventives/remedies for urinary disturbance
12/09/2008US7462619 Pyridazine, pyrimidine and pyrazine ethyne compounds
12/09/2008CA2379061C Antibacterial agents
12/04/2008US20080300239 Quinoline derivatives as pi3 kinase inhibitors
12/04/2008US20080299639 adduct comprising a molecule binding with a kinase; antiinflammatory agents; modulating activation state of p38 kinase protein; switch control ligands to induce or restrict conformation
12/03/2008EP1997818A2 Quinolinone derivatives and their use to treat pain
12/02/2008US7459477 Chemical intermediate for agriculture, horticulture compounds; insecticide, fungicides, miticides
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
11/2008
11/27/2008WO2008144500A2 1-methyl-benzo[1,2,4]thiadiazine, 1-oxide derivatives
11/27/2008US20080293782 1,1,3-Trioxo-1,2,5-Thiadiazolidines and Their Use as Ptp-Ases Inhibitors
11/27/2008US20080293780 Bicyclic aryl-sulfonic acid [1,3,4]-thiadiazol-2-yl-amides, processes for their preparation, pharmaceutical compositions and methods for their use
11/27/2008US20080293776 1,2,5-Thiazolidine Derivatives Useful for Treating Conditions Mediated by Protein Tyrosine Phosphatases (Ptpase)
11/27/2008US20080292588 hepatitis C virus; 5-(4-fluoro-benzyl)-8-hydroxy-7-(1-methyl-1 oxo-1 lambda 6-benzo[1,2,4]thiadiazin-3-yl)-5-aza-spiro[2.5]oct-7-en-6-one
11/26/2008EP1995241A1 Inhibitors of ion channels
11/26/2008CN101312958A 3, 6-dihydro-2-oxo-6H-(1,3,4)thiadiazine derivatives
11/26/2008CN101312957A 1,2,5-thiazolidine derivatives useful for treating conditions mediated by protein tyrosine phosphatases (ptpase)
11/26/2008CN101312956A Substituted 5-phenyl-3,6-dihydro-2-oxo-6H-[1,3,4]thiadiazines
11/26/2008CN100436456C Imidazo [4,5-b] pyridiniummethyl-containing cephem compounds having broad antibacterial spectrum
11/26/2008CN100436432C 2-[(2-methyl-4-hydroxy benzyl)azo]-1,3,4-thiadiazole and its preparation and use
11/20/2008WO2008139845A1 Novel amide derivative
11/19/2008EP1992623A1 Heteroaryl benzamide derivative for use as GLK activator in the treatment of diabetes
11/13/2008WO2008136382A1 Bicyclic compound and pharmaceutical use thereof
11/13/2008US20080280959 Cyclic n-[1,3,4]-thiadiazol-2-yl-benzene sulfonamides, pharmaceutical compositions and methods for the therapeutic use thereof
11/13/2008US20080280915 {1-[6-(trifluoromethyl)pyridin-3-yl]methyl}(methyl)- lambda 4-sulfanylidenecyanamide; especially useful for the control of aphids and other sucking insects
11/13/2008US20080280875 Fused phenyl amido heterocyclic compounds
11/13/2008CA2684703A1 Bicyclic compound and pharmaceutical use thereof
11/11/2008US7449486 Mitotic kinesin inhibitors and methods of use thereof
11/06/2008US20080275233 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
11/06/2008US20080275032 Pyridazinone compounds
11/06/2008US20080275031 Inhibitors of C-FMS Kinase
11/06/2008US20080275023 N-Hydroxyamides Omege-Substituted with Tricyclic Groups as Histone Deacetylase Inhibitors, Their Preparation and Use in Pharmaceutical Formulations
11/05/2008EP1987831A1 Compounds effecting glucokinase
11/05/2008EP1324970B1 Retinoids for the treatment of emphysema
11/04/2008US7446207 Organic dye used in dye-sensitized solar cell
10/2008
10/30/2008WO2008129129A1 Heterocyclic phenyl carbamates as novel faah-inhibitors
10/30/2008WO2008107677A3 Thiadiazole and oxadiazole derivatives for the treatment of neurodegenerative disorders
10/30/2008US20080269221 Antibacterial agents
10/30/2008CA2684340A1 Thiadiazolyloxyphenylamidines and the use thereof as fungicides
10/28/2008US7442760 electroluminescent end capped polyarylenes, for use in electronics such as organic light emitting diodes, having high luminous efficiency and durability
10/28/2008US7442702 Prostaglandin agonists
10/23/2008WO2008128072A2 Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
10/23/2008WO2008021849A3 Novel compounds as antagonists or inverse agonists at opioid receptors
10/23/2008US20080262050 Organic Compounds
10/23/2008US20080262049 Therapeutic Agent for Hematopoietic Tumor
10/23/2008US20080261996 Substituted propiolic acid amides and their use for producing drugs
10/23/2008CA2682733A1 Axl kinase inhibitors
10/22/2008EP1981866A1 Fungicide n-cycloalkyl-benzyl-amide derivatives
10/22/2008EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
10/22/2008EP1981504A2 Thiadiazole derivatives for the treatment of neuro degenerative diseases
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 100